£104.34

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Price data last checked 50 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£104 today · previous high £104 · all-time low £104

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 41 days · 41 data points (no recent data)

Historical
Generating forecast…
£104.34 £104.16 £104.20 £104.24 £104.28 £104.32 £104.36 10 June 2026 20 June 2026 30 June 2026 10 July 2026 20 July 2026

Price Distribution

Price distribution over 41 days • 1 price levels

Days at Price
41 days 0 10 21 31 41 £104 Days at Price

Price Analysis

Most common price: £104 (41 days, 100.0%)

Price range: £104 - £104

Price levels: 1 different prices over 41 days

Description

Stay current with this essential medical resource on plasma cell neoplasms from Springer. This book serves as a comprehensive source of up-to-date information for healthcare professionals managing hematologic malignancies. It provides updated diagnostic frameworks, including new criteria for identifying symptomatic multiple myeloma that requires active treatment. Readers gain access to detailed descriptions of novel therapies recently licensed by the U.S. Food and Drug Administration. The text covers critical advancements in treatment protocols, such as the use of lenalidomide as a first-line therapy. It also examines specialized combinations like panobinostat with bortezomib and dexamethasone for relapsed or refractory cases. Additionally, the book explores the application of ibrutinib for Waldenstrom's macroglobulinemia and other new therapeutic regimens. This volume is a vital addition to any medical library focused on immunology and internal medicine, offering the latest clinical insights into the management of plasma cell disorders.

Key Features

Provides new diagnostic criteria for symptomatic multiple myeloma requiring treatment to assist in accurate clinical assessment.

Covers recently FDA-licensed therapies for myeloma and other plasma cell neoplasms to keep medical practice current.

Details lenalidomide usage as a first-line therapy option for managing patient care effectively.

Includes information on panobinostat in combination with bortezomib and dexamethasone for relapsed or refractory myeloma.

Explains the application of ibrutinib for the treatment of Waldenstrom's macroglobulinemia.

Offers a comprehensive overview of new therapeutic regimens for various hematologic malignancies.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 September 2016
Listed Since
10 September 2015

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
99% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 02 Jul 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 04 Jul 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
98% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£103.26 09 Jul 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
98% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£80.64 30 Jun 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 12 Aug 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
98% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£148.94 14 Aug 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
98% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£62.16 08 Jul 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.32 10 Jul 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.66 09 Jul 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
97% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£108.01 25 Jul 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£80.22 27 Jul 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.27 13 Aug 2026
Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
97% match

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

CRC Press

£84.74 18 Jul 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
97% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.60 14 Aug 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
97% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£85.77 23 Jul 2026
Contemporary Management of Multiple Myeloma
97% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£11.49 07 Jul 2026
Recent Updates on Multiple Myeloma
97% match

Recent Updates on Multiple Myeloma

IntechOpen

£119.00 10 Jul 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
97% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£130.52 15 Aug 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.08 03 Jul 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.10 17 Jul 2026
Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)
96% match

Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)

Springer

£98.34 31 Jul 2026
Springer - Molecular Aspects of Hematologic Malignancies Book
96% match

Springer - Molecular Aspects of Hematologic Malignancies Book

Springer

£108.00 17 Jul 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
96% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Elsevier

£167.99 22 Aug 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026